Skip to content

Drug interactions

Mavacamten + Valproic acid

Severity: Moderate

Mavacamten and Valproic acid: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mavacamten is cleared mainly by CYP2C19 and CYP3A4, so inhibitors can raise its levels and reduce ejection fraction. The inhibitory effect of valproate on these enzymes is weak and not well characterized.

What this interaction means in plain words

Mavacamten and Valproic acid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mavacamten belongs to Cardiovascular; Valproic acid belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible inhibition of CYP2C19 metabolism of mavacamten by valproate.

What to do

Monitor LVEF and clinical status per mavacamten labeling when valproate is started or stopped, and adjust the mavacamten dose per echocardiographic findings.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mavacamten and Valproic acid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mavacamten with Valproic acid?

MediHelp rates the interaction as moderate. Mavacamten and Valproic acid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Mavacamten is cleared mainly by CYP2C19 and CYP3A4, so inhibitors can raise its levels and reduce ejection fraction. The inhibitory effect of valproate on these enzymes is weak and not well characterized.

How serious is the interaction between Mavacamten and Valproic acid?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor LVEF and clinical status per mavacamten labeling when valproate is started or stopped, and adjust the mavacamten dose per echocardiographic findings.

What other medicines interact with Valproic acid?

MediHelp also lists interactions of Valproic acid with, for example, Ertapenem, Imipenem / cilastatin / relebactam, Imipenem / cilastatin. The full list is on the Valproic acid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in